top of page

KETAMINE


Several scientific studies, including those conducted at Yale University and the National Institute of Mental Health, have shown that low dose intravenously administered ketamine can dramatically improve symptoms associated with depression and many anxiety disorders. Often, even when other treatments have failed to provide any relief, IV ketamine is effective. (Krystal et al. 2019)
All new patients have a series of six infusions spaced over two or three weeks. Each infusion is 40 minutes long, painless, and well tolerated. Most patients experience significant relief during the series and many remain symptom free for extended periods of time following the initial treatment protocol.
Ketamine therapy impacts both mood and anxiety disorders with positive treatment outcomes for the following diagnoses:
-
Depression, Chronic Depression, and Treatment Resistant Depression
-
Post Traumatic Stress Disorder (PTSD)
-
Bipolar Disorder
-
Obsessive Compulsive Disorder (OCD)
-
Post Partum Depression
-
All Anxiety Disorders
OUR PRACTICE
BRITT BEASLEY, MD
Dr. Beasley is double boarded in General Psychiatry and Addiction Medicine

AREAS OF INTEREST
Neurobiology and treatment of difficult-to-treat depression, other mood disorders, trauma and anxiety disorders
PRACTICING SINCE 2010
BS, UNC Chapel Hill
MD, VCU School of Medicine
General Psychiatry, Mount Sinai Hospital
Contact Us
A member of out team will answer your questions, and help set up you appointments.

bottom of page